报价延迟最少15分钟:2026/05/16 16:46 EDT
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
3.98 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-0.35/--
|
|
企业价值
500.46M
|
| 资产负债 |
|
每股账面净值
-0.16
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
502.73M
|
|
每股收益
2.93
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比较之报价最少15分钟延迟 (夜盘时段除外)
|
业务概览
|
|||
| The Oncology Institute Inc offers oncology care and treatment services to patients through several clinics located across the United States. It offers services such as infusion chemotherapy, oral drug chemotherapy, hospice and palliative care, autologous stem cell transplants, outpatient blood product transfusions, patient navigator programs, radiation oncology, and others on a fee or value-based model. Additionally, the company enrolls patients in clinical trials, where appropriate. The company has three operating segments: Specialty Pharmacy, Patient Services, and Clinical Trials and Other. Maximum revenue is generated from the Specialty Pharmacy segment, which operates specialty and retail pharmacies providing IV-infused, oral, injectable, and other medications for oncology treatment. |
